Williams Paul Anthony
SVP, Products Business
Williams Paul Anthony has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
On the most recent filing, Williams Paul Anthony is listed as SVP, Products Business at Emergent BioSolutions Inc. Inside the rolling window, Williams Paul Anthony reported no open-market purchases and 2 open-market sales totaling $59K in EBS. The largest disclosed transaction in the window is a sale of 4,000 EBS shares on Apr 1, 2026, worth $34K.
Companies traded
Other insiders at EBS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$59K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Paul Anthony made?
Williams Paul Anthony has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Williams Paul Anthony trade?
Williams Paul Anthony has filed SEC Form 4 disclosures for 1 company, including EBS.
When was Williams Paul Anthony's most recent SEC Form 4 filing?
Williams Paul Anthony's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.
What is Williams Paul Anthony's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Williams Paul Anthony is listed as SVP, Products Business.
What is Williams Paul Anthony's total buy and sell value in the current window?
Inside the rolling retention window, Williams Paul Anthony bought $0 and sold $59K based on SEC Form 4 filings.
What was Williams Paul Anthony's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,000 EBS shares on 2026-04-01, worth $34K, per SEC Form 4 filings.